OMSmartData Launch: China's Largest Pan-Cancer Real-World Database Focused on Pharmaceutical Enterprises

OrigiMed Showcases Latest Research Findings at the 2024 ESMO

2024 ASCO | Deepening Pharmaceutical Collaboration, Accelerating Drug Development with New Technologies and Multi-platform Advantages

OrigiMed's SmartMTB Takes the Lead at the AACR 2024

The New Base of OrigiMed Fully Committed to Creating a Benchmark for High-End Biopharmaceutical Industry